Analysis of management and treatment of patients with severe mental disorders in Chengdu from 2016 to 2020
10.11886/scjsws20220624001
- VernacularTitle:2016年-2020年成都市严重精神障碍患者管理治疗分析
- Author:
Guoju MAO
1
;
Xiaorong QIN
1
;
Lanling FENG
1
;
Zixiang YE
1
;
Yan ZHAO
1
;
Qin YANG
1
;
Changjiu HE
1
Author Information
1. The Fourth People's Hospital of Chengdu， Chengdu 610036， China
- Publication Type:Journal Article
- Keywords:
Severe mental disorders;
Community mental health services;
Medication adherence;
Information system
- From:
Sichuan Mental Health
2022;35(6):550-555
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo analyze the management and treatment for patients with severe mental disorders in Chengdu from 2016 to 2020， in order to provide references for the relevant authorities to formulate policies and improving the mental health service system. MethodsData relating to 22 districts （cities） and counties in Chengdu from January 1， 2016 to December 31， 2020 were extracted from the National Information System for Severe Mental Disorders. Indicators such as reported prevalence rate， management rate， standardized management rate， medication rate， regular medication rate and stable condition rate of patients with severe mental disorders were analyzed on a yearly basis. ResultsBy the end of 2020， there were 71 899 registered cases of severe mental disorders in Chengdu， with a reported prevalence rate of 0.34%， a standardized management rate of 95.53%， and a regular medication rate of 72.50%. From 2016 to 2020， except the reported prevalence rate （χ²=269.566， P<0.01）， management rate （χ²=384.030， P<0.01）， standardized management rate （χ²=309.742， P<0.01）， medication rate （χ²=414.252， P<0.01）， regular medication rate （χ²=316.172， P<0.01） and stable condition rate （χ²=288.335， P<0.01） had linear trends of increasing with the annual increase. ConclusionFrom 2016 to 2020， the management rate， treatment rate and regular medication rate of patients with severe mental disorders have been increased year by year in Chengdu. Nevertheless， the increase in reported prevalence rate should be accompanied by strengthened management and follow-up to increase the regular medication rate to maintain the stability of patients' conditions.
